ANGO vs TCMD: stock comparison and AI forecast
Angiodynamics Inc (ANGO) and Tactile Systems Technology Inc (TCMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ANGO Angiodynamics Inc
- Price
- $11.76 +7.1% · 6M
- Market Cap
- $493M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
TCMD Tactile Systems Technology Inc
- Market Cap
- $518M
- P/E Ratio
- 29.7x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ANGO and TCMD have similar market capitalizations ($493M and $518M).
- TCMD turns 6.7% of its revenue into net income, against -11.4% for ANGO.
- ANGO carries 0.48 times debt per unit of equity, against 0.28 times for TCMD.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ANGO | TCMD |
|---|---|---|
| Market Cap | $493M | $518M |
| P/E Ratio | – | 29.70x |
| P/B Ratio | 3.01x | 2.28x |
| EPS | $-0.79 | $0.77 |
| Book Value/Share | $3.90 | $10.03 |
| Revenue/Share | $7.74 | $15.73 |
| FCF/Share | $0.03 | $1.28 |
Profitability & Margins
| Metric | ANGO | TCMD |
|---|---|---|
| ROE | -23.2% | 10.5% |
| ROA | -15.7% | 8.2% |
| ROIC | -20.1% | 13.8% |
| Gross Margin | 55.6% | 77.0% |
| Operating Margin | -11.0% | 9.4% |
| Net Margin | -11.4% | 6.7% |
| EBT Margin | -9.8% | 10.1% |
| Tax Rate | -0.5% | 33.9% |
Financial Health
| Metric | ANGO | TCMD |
|---|---|---|
| Current Ratio | 2.40x | 3.51x |
| Quick Ratio | 1.48x | 3.18x |
| D/E Ratio | 0.48x | 0.28x |
| Financial Leverage | 1.48x | 1.28x |
| Interest Coverage | 25.5x | 383.6x |
| Working Capital | $83M | $119M |
Cash Flow
| Metric | ANGO | TCMD |
|---|---|---|
| Operating Cash Flow | $4M | $32M |
| Free Cash Flow | $1M | $29M |
| Capital Spending | -$2M | -$3M |
| OCF Growth YoY | – | -23.1% |
| FCF Growth YoY | – | -26.6% |
| FCF/Sales | 0.4% | 8.1% |
| CapEx/Sales | 0.7% | 0.9% |
Operational Efficiency
| Metric | ANGO | TCMD |
|---|---|---|
| Asset Turnover | 1.34x | 1.22x |
| Receivables Turnover | 7.2x | 7.4x |
| Inventory Turnover | 2.6x | 5.3x |
| Fixed Assets Turnover | 11.7x | 62.7x |
| Days Sales Outstanding | 50 days | 49 days |
| Days Inventory | 139 days | 69 days |
| Payables Period | 67 days | 53 days |
| Cash Conversion Cycle | 122 days | 66 days |
Income Statement
| Metric | ANGO | TCMD |
|---|---|---|
| Total Revenue | $325M | $356M |
| Operating Income | -$37M | $34M |
| Net Income | -$38M | $24M |
| R&D Expense | $31M | $10M |
| SG&A Expense | $187M | $246M |
| Cost of Goods Sold | $144M | $82M |
Dividend & Shareholder Information
| Metric | ANGO | TCMD |
|---|---|---|
| Shares Outstanding | 42M | 23M |
| Net Income Growth | – | 31.1% |
| EPS Growth | – | -9.4% |
ANGO vs TCMD: stock comparison and AI forecast
Which is bigger, ANGO or TCMD?
ANGO and TCMD have similar market capitalizations ($493M and $518M).
Which one does Intratio's AI model rank higher, ANGO or TCMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.